173 related articles for article (PubMed ID: 35142621)
1. Cancer Screening Recommendations During the COVID-19 Pandemic: Scoping Review.
Shah SK; McElfish PA
JMIR Cancer; 2022 Feb; 8(1):e34392. PubMed ID: 35142621
[TBL] [Abstract][Full Text] [Related]
2. Rapid adaptation of cancer screening practices during COVID-19: A multi-state qualitative study.
Turner K; Tabriz AA; Hong YR; Arredondo B; Menon U; Hanna K; Vadaparampil S; Christy S; Islam J; Chavez M; Kue J; Szalacha L
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36857283
[TBL] [Abstract][Full Text] [Related]
3. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
[TBL] [Abstract][Full Text] [Related]
4. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
5. Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects.
Fisher-Borne M; Isher-Witt J; Comstock S; Perkins RB
Prev Med; 2021 Oct; 151():106681. PubMed ID: 34217422
[TBL] [Abstract][Full Text] [Related]
6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
8. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
9. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
10. Trends in breast cancer screening during the COVID-19 pandemic within a universally insured health system in the United States, 2017-2022.
Mani V; Banaag A; Munigala S; Umoh A; Schoenfeld AJ; Coles CL; Koehlmoos TP
Cancer Med; 2023 Sep; 12(18):19126-19136. PubMed ID: 37641528
[TBL] [Abstract][Full Text] [Related]
11. Integrated interventions and supporting activities to increase uptake of multiple cancer screenings: conceptual framework, determinants of implementation success, measurement challenges, and research priorities.
Subramanian S; Tangka FKL; Hoover S; DeGroff A
Implement Sci Commun; 2022 Oct; 3(1):105. PubMed ID: 36199098
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of Leveraging Social Determinants of Health to Improve Breast, Cervical, and Colorectal Cancer Screening: A Systematic Review.
Mohan G; Chattopadhyay S
JAMA Oncol; 2020 Sep; 6(9):1434-1444. PubMed ID: 32556187
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Low-Value Cancer Screenings in the Veterans Health Administration.
Schuttner L; Haraldsson B; Maynard C; Helfrich CD; Reddy A; Parikh T; Nelson KM; Wong E
JAMA Netw Open; 2021 Oct; 4(10):e2130581. PubMed ID: 34677595
[TBL] [Abstract][Full Text] [Related]
14. Impact of COVID-19 on Screening Rates for Colorectal, Breast, and Cervical Cancer: Practice Feedback From a Quality Improvement Project in Primary Care.
Schad LA; Brady LA; Tumiel-Berhalter LM; Bentham A; Vitale K; Norton A; Noronha G; Swanger C; Morley CP
J Patient Cent Res Rev; 2021; 8(4):347-353. PubMed ID: 34722804
[TBL] [Abstract][Full Text] [Related]
15. A Review of the Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: Implications and Solutions.
Sundaram S; Olson S; Sharma P; Rajendra S
Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832663
[TBL] [Abstract][Full Text] [Related]
16. A review on utilizing machine learning technology in the fields of electronic emergency triage and patient priority systems in telemedicine: Coherent taxonomy, motivations, open research challenges and recommendations for intelligent future work.
Salman OH; Taha Z; Alsabah MQ; Hussein YS; Mohammed AS; Aal-Nouman M
Comput Methods Programs Biomed; 2021 Sep; 209():106357. PubMed ID: 34438223
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis.
Muschol J; Strauss C; Gissel C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5345-5367. PubMed ID: 36436091
[TBL] [Abstract][Full Text] [Related]
18. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
